postmenopausal osteoporosis

ATELVIA® (risedronate sodium)

ATELVIA® (risedronate sodium)

Risedronate has an affinity for hydroxyapatite crystals in bone and acts as an antiresorptive agent. At the cellular level, risedronate inhibits osteoclasts. The osteoclasts adhere normally to the bone surface, but show evidence of reduced active resorption